Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Depression screening in HIV-positive Tanzanian adults: comparing the PHQ-2, PHQ-9 and WHO-5 questionnaires.

Nolan CP, O'Donnell PJM, Desderius BM, Mzombwe M, McNairy ML, Peck RN, Kingery JR.

Glob Ment Health (Camb). 2018 Nov 19;5:e38. doi: 10.1017/gmh.2018.31. eCollection 2018.

2.

Heart failure, post-hospital mortality and renal function in Tanzania: A prospective cohort study.

Kingery JR, Yango M, Wajanga B, Kalokola F, Brejt J, Kataraihya J, Peck R.

Int J Cardiol. 2017 Sep 15;243:311-317. doi: 10.1016/j.ijcard.2017.05.025. Epub 2017 May 9.

3.

Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure.

Kingery JR, Hamid T, Lewis RK, Ismahil MA, Bansal SS, Rokosh G, Townes TM, Ildstad ST, Jones SP, Prabhu SD.

Basic Res Cardiol. 2017 Mar;112(2):19. doi: 10.1007/s00395-017-0609-2. Epub 2017 Feb 25.

4.

Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in Tanzania.

Kingery JR, Alfred Y, Smart LR, Nash E, Todd J, Naguib MR, Downs JA, Kalluvya S, Kataraihya JB, Peck RN.

Heart. 2016 Aug 1;102(15):1200-5. doi: 10.1136/heartjnl-2015-309026. Epub 2016 Apr 22.

5.

Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients.

Tisdale JE, Jaynes HA, Kingery JR, Overholser BR, Mourad NA, Trujillo TN, Kovacs RJ.

Circ Cardiovasc Qual Outcomes. 2014 May;7(3):381-90. doi: 10.1161/CIRCOUTCOMES.113.000651. Epub 2014 May 6. Erratum in: Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):981.

6.

Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis.

Ismahil MA, Hamid T, Bansal SS, Patel B, Kingery JR, Prabhu SD.

Circ Res. 2014 Jan 17;114(2):266-82. doi: 10.1161/CIRCRESAHA.113.301720. Epub 2013 Nov 1.

7.

Development and validation of a risk score to predict QT interval prolongation in hospitalized patients.

Tisdale JE, Jaynes HA, Kingery JR, Mourad NA, Trujillo TN, Overholser BR, Kovacs RJ.

Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):479-87. doi: 10.1161/CIRCOUTCOMES.113.000152. Epub 2013 May 28. Erratum in: Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):e57.

8.

High risk of QT interval prolongation and torsades de pointes associated with intravenous quinidine used for treatment of resistant malaria or babesiosis.

Wroblewski HA, Kovacs RJ, Kingery JR, Overholser BR, Tisdale JE.

Antimicrob Agents Chemother. 2012 Aug;56(8):4495-9. doi: 10.1128/AAC.06396-11. Epub 2012 May 21.

9.
10.

Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunction.

Tisdale JE, Overholser BR, Wroblewski HA, Sowinski KM, Amankwa K, Borzak S, Kingery JR, Coram R, Zipes DP, Flockhart DA, Kovacs RJ.

J Clin Pharmacol. 2012 Sep;52(9):1296-305. doi: 10.1177/0091270011416939. Epub 2011 Nov 1.

11.

Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.

Hamid T, Guo SZ, Kingery JR, Xiang X, Dawn B, Prabhu SD.

Cardiovasc Res. 2011 Jan 1;89(1):129-38. doi: 10.1093/cvr/cvq274. Epub 2010 Aug 25.

12.

Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.

Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, Kingery JR, Lewis RK, Li Q, Rokosh DG, Ford R, Spinale FG, Riggs DW, Srivastava S, Bhatnagar A, Bolli R, Prabhu SD.

Circulation. 2010 May 4;121(17):1912-25. doi: 10.1161/CIRCULATIONAHA.109.905471. Epub 2010 Apr 19.

13.

Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.

Tisdale JE, Overholser BR, Sowinski KM, Wroblewski HA, Amankwa K, Borzak S, Kingery JR, Coram R, Zipes DP, Flockhart DA, Kovacs RJ.

Pharmacotherapy. 2008 Dec;28(12):1461-70. doi: 10.1592/phco.28.12.1461.

PMID:
19025427
14.

Vancomycin assay performance in patients with end-stage renal disease receiving hemodialysis.

Kingery JR, Sowinski KM, Kraus MA, Klaunig JE, Mueller BA.

Pharmacotherapy. 2000 Jun;20(6):653-6.

PMID:
10853620

Supplemental Content

Loading ...
Support Center